Ophthalmology

New Study Finds Nearly Fivefold Higher Reported ‘Eye Stroke’ Risk With Wegovy vs Ozempic

A retrospective FDA adverse‑event analysis reported the signal, prompting regulator warnings and calls for prospective studies.